On Nov. 12 Abbott  achieved the highest score out of 84 companies in its industry in the S&P Global Corporate Sustainability Assessment, also called the Dow Jones Sustainability Index . This was the ninth consecutive year that Abbott has secured the top score in the Health Care Equipment & Supplies sector, and the 17 th consecutive year that Abbott has been included on the Dow Jones Sustainability World Index and ...

On Nov. 12 Abbott (NYSE: ABT) achieved the highest score out of 84 companies in its industry in the S&P Global Corporate Sustainability Assessment, also called the Dow Jones Sustainability Index (DJSI). This was the ninth consecutive year that Abbott has secured the top score in the Health Care Equipment & Supplies sector, and the 17 th consecutive year that Abbott has been included on the Dow Jones Sustainability World Index and North America Index. The DJSI measures the performance of companies using environmental, social and governance (ESG) criteria and is considered one of the most prestigious global benchmarks for corporate sustainability.

Abbott's continued strong performance on the DJSI reflects the company's longstanding commitment to sustainability in health. Abbott's 2030 Sustainability Plan focuses on innovating for greater access to life-changing technologies and breaking down barriers to health equity to reach more people in more places than ever before.

"The emphasis of our 2030 Sustainability Plan is on the priority where we can make the greatest impact and do the most good for the most people: in focusing our future innovation on creating products that are affordable and accessible to more people than ever before," said Robert B. Ford , president and chief executive officer, Abbott. "Using our primary expertise to help the world achieve greater total health at lower total cost is the most meaningful way we can contribute to the long-term sustainability of our society and our planet."

Abbott scored 83 (out of 100) in the 2021 S&P Global Corporate Sustainability Assessment, achieving the highest industry score in nine of 25 total criteria, including strategy to improve access to drugs or products, health outcome contribution, social reporting, human capital development, information security/cybersecurity & systems availability, marketing practices, materiality, environmental reporting, and occupational health and safety.

Abbott recently released its 2020 Sustainability Report Summary , which shares its high-level global performance in key areas, including innovating for access and affordability, building the workforce of tomorrow, protecting the environment, responsibly applying data to advance care, building a more resilient supply chain, and delivering product quality and safety. For detailed information about our materiality process, policies, management approach, performance and targets for all our environmental, social and governance (ESG) priorities, see our full Global Sustainability Report .

For more information on the Dow Jones Sustainability Index, please see the S&P Global website and the DJSI news release .

To learn more about Abbott's approach to sustainability and its 2030 Sustainability Plan, please visit www.abbott.com/sustainability .

About Abbott:
Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com , on LinkedIn at www.linkedin.com/company/abbott-/ , on Facebook at http://www.facebook.com/Abbott and on Twitter @AbbottNews .

Cision View original content: https://www.prnewswire.com/news-releases/abbott-achieves-highest-score-in-its-industry-for-the-ninth-consecutive-year-on-the-dow-jones-sustainability-index-djsi-301424215.html

SOURCE Abbott

News Provided by PR Newswire via QuoteMedia

Knight to Present at Stifel GMP's The Future of Healthcare Conference

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading pan-American (ex-US) specialty pharmaceutical company, is pleased to announce that Samira Sakhia, President and Chief Executive Officer, is scheduled to present at the upcoming Stifel GMP Future of Healthcare Conference on Wednesday, December 8, 2021 at 10 am ET, that will be held virtually. A live webcast of the event will be available at the following link: Event . A copy of the presentation will be available at www.gud-knight.com .

About Knight Therapeutics Inc.

Keep reading... Show less

IDBS Polar Insight Brings Advanced Data Analytics and Visualization to BioPharma Lifecycle Management

IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform.

Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.

Keep reading... Show less

Medtronic receives Health Canada licence for GI Genius intelligent endoscopy module with artificial intelligence system for colonoscopy

Transformative AI System Enhances Colorectal Cancer Detection Capabilities

 Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the global leader in medical technology — announced it has received a Health Canada licence for the GI Genius™ intelligent endoscopy module. GI Genius is a computer-aided detection (CADe) system that uses artificial intelligence (AI) to highlight regions of the colon suspected to have visual characteristics consistent with different types of mucosal abnormalities.

Keep reading... Show less
Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant

Beyond Medical Technologies Ramps Up COVID Mask Manufacturing in Response to New South Africa COVID Variant

Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM4) ("Beyond Medical" or the "Company") is pleased to provide the following corporate update regarding its wholly-owned subsidiary Micron Technologies Inc. ("Micron Technologies").

Keep reading... Show less
Leveljump Q3 Earnings and Results; Record Quarterly Revenues

Leveljump Q3 Earnings and Results; Record Quarterly Revenues

LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce today it has reported financial results for the third fiscal quarter ended September 30th, 2021. All amounts are expressed in Canadian dollars.

Financial and Operational Highlights

Keep reading... Show less

Thermo Fisher Scientific Confirms Detection of SARS-CoV-2 in Samples Containing the Omicron Variant with its TaqPath COVID-19 Tests

- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit *, and TaqPath COVID-19 CE-IVD RT-PCR Kit *, which test for the presence of SARS-CoV-2, are not impacted by the emerging B.1.1.529, or Omicron variant, enabling accurate test results.

The Omicron variant, which was designated a " variant of concern " by the World Health Organization (WHO), has more than 30 mutations in the spike protein alone. The WHO has reported that preliminary evidence suggests an increased risk of transmission compared to other variants of concern. This designation and information are leading to renewed travel restrictions and research to examine the variant's impact on efficacy of existing vaccines and tests. The WHO and European Centers for Disease Control have both reported that using S-gene target failure (SGTF) of the PCR assays as a proxy for the variant helped to identify Omicron. Cases of the variant were first identified in South Africa and have now been reported in at least a dozen countries around the world.

Keep reading... Show less

Top News

Related News